BioLineRx (BLRX) EPS (Basic) (2011 - 2025)

BioLineRx (BLRX) posted quarterly EPS (Basic) of -$0.0 for Q4 2025, up 65.9% year-over-year from -$0.0 in Q4 2024, and down 142.02% quarter-over-quarter from -$0.0 in Q3 2025.

BioLineRx (BLRX) EPS (Basic) (2011 - 2025) Analysis & Trends

BioLineRx's EPS (Basic) history runs 11 years deep, the most recent figure standing at -$0.0 for Q4 2025.

  • In Q4 2025, EPS (Basic) rose 65.9% year-over-year to -$0.0; the TTM figure through Dec 2025 stood at -$0.0 (up 56.8% YoY), while the FY2025 annual figure was -$0.0, up 93.81% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$0.0, down from -$0.0 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.0 in Q1 2025, with the low at -$0.0 in Q4 2024.
  • The 3-year median for EPS (Basic) is -$0.0 (2023), against an average of -$0.0.
  • Peak annual rise in EPS (Basic) reached 65.9% in 2025, while the deepest fall reached 8871.72% in 2025.
  • BioLineRx's EPS (Basic) stood at -$0.0 in 2023, then plunged by 344.56% to -$0.0 in 2024, then jumped by 65.9% to -$0.0 in 2025.
  • Business Quant data shows BLRX's EPS (Basic) at -$0.0 in Q4 2025, -$0.0 in Q3 2025, and -$0.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 BioLineRx 7.21 Bn 7.21 Bn 154,000.00 0.00

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Jun 30, 2024 0.00
Dec 31, 2023 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Sep 30, 2018 0.00
Jun 30, 2018 0.00
Mar 31, 2018 0.00
Dec 31, 2017 0.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2016 0.00
Mar 31, 2016 0.00